{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T05:21:30Z","timestamp":1737609690244,"version":"3.33.0"},"reference-count":0,"publisher":"Ecancer Global Foundation","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ecancer Journal"],"DOI":"10.3332\/ecancer.2025.1829","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T10:19:44Z","timestamp":1737541184000},"source":"Crossref","is-referenced-by-count":0,"title":["Is the gemcitabin-cisplatin combination the optimal induction chemotherapy for non-Asian patients with nasopharyngeal carcinoma (NPC)? Insights from a cohort in north-eastern Morocco"],"prefix":"10.3332","volume":"19","author":[{"given":"Oumaima","family":"Talbi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khadija","family":"Hinaje","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samia","family":"Mhirech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoutar","family":"Maadin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imad","family":"Chakri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lamiae","family":"Amaadour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karima","family":"Oualla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zineb","family":"Benbrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Touria","family":"Bouhafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nawfel","family":"Mellas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samia","family":"Arifi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1871","published-online":{"date-parts":[[2025,1,22]]},"container-title":["ecancermedicalscience"],"original-title":[],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T10:19:44Z","timestamp":1737541184000},"score":1,"resource":{"primary":{"URL":"https:\/\/ecancer.org\/en\/journal\/article\/1829-is-the-gemcitabin-cisplatin-combination-the-optimal-induction-chemotherapy-for-non-asian-patients-with-nasopharyngeal-carcinoma-npc-insights-from-a-cohort-in-north-eastern-morocco"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,22]]},"references-count":0,"URL":"https:\/\/doi.org\/10.3332\/ecancer.2025.1829","relation":{},"ISSN":["1754-6605"],"issn-type":[{"value":"1754-6605","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,22]]}}}